Evaluating cardiovascular outcomes in liver transplant patients
Evaluation of Cardiovascular Outcomes in Patients Undergoing Orthotopic Liver Transplantation: a Retrospective Cohort Study
University of Campania Luigi Vanvitelli · NCT05895669
This study looks at the heart health of people who have received a liver transplant to see how their recovery and treatments affect their overall well-being over two years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Campania Luigi Vanvitelli (other) |
| Locations | 2 sites (Gragnano, SA and 1 other locations) |
| Trial ID | NCT05895669 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect and analyze data from patients who have undergone orthotopic liver transplantation at participating centers. It will involve characterizing these patients and their therapies while assessing prognostic factors related to significant clinical outcomes, including cardiovascular complications. The study will follow patients for at least two years to gather comprehensive data on their health status and any complications that arise post-transplant.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals who have received an orthotopic liver transplant and have been followed for at least two years.
Not a fit: Patients who have not provided informed consent or lack contact information for follow-up will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of cardiovascular risks in liver transplant patients, leading to better management and outcomes.
How similar studies have performed: While this study is observational and builds on existing knowledge, similar studies have shown success in identifying cardiovascular risks in transplant populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients with ortothopic liver transplantation and at least 2 year follow-up at the referral center Exclusion Criteria: * Missing Informed Consent Form * Missing Contact Informations for Follow up
Where this trial is running
Gragnano, SA and 1 other locations
- Gragnano Hospital — Gragnano, SA, Italy (RECRUITING)
- University of Campania Luigi Vanvitelli — Napoli, Italy (RECRUITING)
Study contacts
- Study coordinator: Alfredo Caturano, MD
- Email: alfredo.caturano@unicampania.it
- Phone: +393338616985
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Liver Transplant, Complications, Cardiovascular Complication, Cardiovascular, Attack, Cardiovascular Stroke, Death